Condiciones de salud que fenogreco puede ayudar a apoyar.
Fenugreek's mucilaginous fiber coats the gastrointestinal lining and reduces gastric and intestinal inflammation, alleviating bloating and abdominal pain. Clinical evidence from GI-focused trials reports reduced bloating with fenugreek use; its most common side effects are also GI-related, confirming direct GI activity.
Fenugreek's soluble fiber fraction (galactomannan) forms a viscous raft in the stomach that acts as a physical barrier against acid reflux. A small placebo-controlled randomized trial found a fenugreek fiber product was as effective as ranitidine 75 mg twice daily in reducing heartburn severity over two weeks. Traditional use in Ayurveda and Mediterranean medicine for gastric complaints is also documented.
A 2024 randomized double-blind trial in 95 men aged 40–80 found fenugreek extract at 1800 mg/day significantly increased the free testosterone index by 12.2% and raised salivary testosterone by 37.2% versus placebo at 12 weeks. Rao et al. demonstrated fenugreek seed extract (600 mg/day for 12 weeks) alleviated andropause symptoms and improved blood testosterone in men aged 43–75 with age-related androgen deficiency. Its active compounds (furostanolic saponins including protodioscin) are proposed to inhibit aromatase and 5-alpha-reductase.
Fenugreek seeds contain multiple antioxidant compounds—flavonoids, trigonelline, diosgenin, and polyphenols—that enhance endogenous antioxidant enzyme activity (SOD, glutathione peroxidase, glutathione-S-transferase, catalase) and reduce lipid peroxidation. This activity is well-documented across preclinical and clinical metabolic studies.
Fenugreek seeds contain high-viscosity soluble fiber (galactomannan) that swells in the stomach and slows gastric emptying, significantly reducing hunger and next-meal caloric intake in RCTs. A single-blind randomized crossover trial in 18 obese subjects found 4–8 g fenugreek fiber at breakfast significantly lowered hunger ratings and reduced subsequent caloric intake. Traditional Ayurvedic, Chinese, and Middle Eastern use for appetite and digestive regulation spans over 2,000 years.
Fenugreek seeds and mucilage have demonstrated significant anti-arthritic effects in preclinical animal models via inhibition of NF-κB, suppression of COX/LOX pathways, and reduction of TNF-α, IL-6, paw edema, and arthritic index. Clinical trial evidence in human arthritis patients is limited; the preclinical evidence base is robust.
Multiple RCTs and a 2023 systematic review of six RCTs demonstrate that fenugreek supplementation significantly improves muscle strength, endurance, lean body mass, and reduces body fat percentage in resistance-trained individuals. Fenugreek glycosides (sapogenins and saponins) exhibit anabolic and androgenic activity, influencing testosterone levels. Evidence for glycogen resynthesis benefit during post-exercise recovery is mixed.
A 2023 systematic review and meta-analysis of RCTs (Springer Nature, High Blood Pressure & Cardiovascular Prevention) was conducted to assess fenugreek's effect on systolic and diastolic blood pressure. A double-blind RCT in T2DM patients also showed significant reductions in diastolic blood pressure with 5 g/day fenugreek powder for two months.
Fenugreek seeds have a long history of use as a traditional diabetes remedy across Asia and the Middle East. Clinical trial meta-analyses show fenugreek can reduce fasting and postprandial blood glucose in T2DM and prediabetes patients. Mechanisms include inhibition of carbohydrate-digesting enzymes, enhanced GLUT4 translocation, and insulinotropic effects.
Fenugreek (Trigonella foenum-graecum) is the most widely used herbal galactagogue worldwide, with multiple randomized controlled trials and systematic reviews supporting its use for increasing breast milk supply. A 2020 review of 9 clinical trials found positive effects on breast milk adequacy compared to control groups. Proposed mechanisms include modulation of the insulin/GH/IGF-1 axis and stimulation of oxytocin secretion. Evidence quality varies across studies and some meta-analyses show mixed results.
Fenugreek seed demonstrates significant lipid-lowering effects across six meta-analyses of RCTs in adults with type 2 diabetes or hyperlipidemia, with pooled TC reductions of −9 to −33 mg/dL and LDL-C reductions of −7 to −29 mg/dL. Soluble galactomannans and saponins are the primary active components.
Fenugreek seeds possess documented anti-inflammatory properties mediated through inhibition of NF-κB activation, suppression of COX/LOX pathways, and reduction of pro-inflammatory cytokines such as TNF-α and IL-6. These effects are supported primarily by preclinical studies; direct clinical trial evidence in chronic inflammatory conditions in humans remains limited. Antioxidant compounds (flavonoids, trigonelline) provide concurrent protection against oxidative stress.
Fenugreek seeds are rich in water-soluble fiber (galactomannan) that promotes stool softening and improved intestinal transit. The mucilaginous properties of seeds coat the intestinal lining, easing passage. Evidence is primarily based on known fiber physiology and traditional use, with limited dedicated clinical trials on constipation as a primary endpoint.
Fenugreek's galactomannan fiber has been shown to slow gastric emptying and moderate intestinal sodium-dependent glucose uptake, demonstrating direct activity on digestive enzyme and transporter systems. Fenugreek also stimulates insulin secretion by altering metabolic enzyme activity, with documented effects on hepatic glycogen phosphorylase and intestinal brush border function.
Fenugreek (Trigonella foenum-graecum) has been studied for male sexual function in clinical trials, primarily for libido and sexual arousal, with some evidence for erectile function. A randomized, double-blind, placebo-controlled crossover study (World J Mens Health, 2021) found a combination including testofen (fenugreek extract) and L-citrulline significantly improved IIEF scores including erectile function domains. Fenugreek's furostanolic saponins may modulate testosterone levels.
Fenugreek contains phytoestrogens—notably diosgenin and protodioscin—that bind estrogen receptors and raise plasma estradiol. Clinical RCTs in peri- and postmenopausal women report significant increases in circulating estradiol with standardized fenugreek seed extract. These estrogenic effects underlie documented benefits on vasomotor symptoms, mood, and hormonal balance.
Fenugreek (Trigonella foenum-graecum) has traditional use in Ayurveda and as a culinary herb for male reproductive health. A clinical study with FurosapTM fenugreek seed extract in healthy male volunteers found improvements in free testosterone and sperm profile. A 2017 systematic review rated fenugreek among botanicals with the strongest evidence for testosterone improvement and seminal parameter enhancement.
Fenugreek extract has shown potential to improve female fertility markers in the context of PCOS by modulating LH and FSH levels, reducing cyst size, and normalizing menstrual cycles in clinical research. Its phytoestrogenic compounds may support ovarian hormone balance relevant to fertility.
Fenugreek has been reported as a GLP-1 modulator, AMPK activator, and DPP-IV inhibitor in peer-reviewed research. Its seed extract contains a compound (N55) that potentiates GLP-1 signaling, supported by a J Biol Chem study. Clinical trials show fenugreek improves blood glucose, insulin resistance, and insulin sensitivity.
A randomized, placebo-controlled clinical trial of a fenugreek-seed-containing food supplement demonstrated successful treatment of low-to-moderate hair loss and improvement in hair growth in both men and women. Fenugreek's phytoestrogenic and protein-rich profile is proposed to nourish hair follicles.
A randomized, placebo-controlled clinical trial demonstrated successful treatment of low-to-moderate androgenetic alopecia with a fenugreek seed extract supplement in both men and women. A review of the evidence base for fenugreek in androgenetic alopecia confirms clinical and preclinical support, with topical and oral applications studied.
Fenugreek seeds contain galactomannan fiber and saponins that slow gastric emptying, promote satiety, reduce appetite, and improve insulin sensitivity. Multiple RCTs show fenugreek supplementation significantly reduces appetite, caloric intake, and body fat in overweight individuals, with effects partly mediated through glucose and insulin regulation.
Multiple systematic reviews and meta-analyses of RCTs show fenugreek supplementation significantly reduces total cholesterol, LDL-C, and triglycerides, while raising HDL-C, in subjects with metabolic syndrome and type 2 diabetes. These lipid-modulating effects reduce cardiovascular risk factors. Additional antioxidant and anti-inflammatory properties provide further cardioprotective benefit.
Standardized fenugreek seed extract has demonstrated significant reductions in hot flash frequency in menopausal women in multiple RCTs. One 90-day RCT with 1,000 mg/day reported a 47.8% decrease in hot flashes, with 32% of fenugreek-group women reporting complete resolution. The effect is attributed to fenugreek's phytoestrogenic activity increasing circulating estradiol.
Fenugreek seeds have been used for thousands of years in Ayurvedic and Mediterranean traditional medicine for blood sugar management. Active 4-hydroxyisoleucine stimulates glucose-dependent insulin secretion; its soluble fiber slows glucose absorption. A systematic review of 10 RCTs found fenugreek supplementation significantly reduced fasting and postprandial blood glucose in type 2 diabetic patients.
Fenugreek seeds contain multiple bioactive compounds—including 4-hydroxyisoleucine, saponins, and fiber—that collectively improve insulin sensitivity, glucose-dependent insulin secretion, and glycemic control. Clinical trials have shown fenugreek improves blood glucose, insulin resistance, and lipid profiles in T2DM patients. The NIH Endotext lists it as both a carbohydrate absorption inhibitor and an insulin sensitizer.
Fenugreek (Trigonella foenum-graecum) seed extract has shown significant improvement in menstrual cycle regularity in women with PCOS. A clinical study found that after fenugreek treatment, 71% of patients with irregular PCOS cycles achieved regular cycles. It reduces insulin resistance and has anti-diabetic properties relevant to the PCOS-related cycle irregularity mechanism.
Fenugreek (Trigonella foenum-graecum) seeds contain furostanolic saponins (fenuside) that inhibit aromatase and 5-alpha-reductase, thereby supporting free testosterone levels. A 2011 double-blind, placebo-controlled RCT in 60 healthy men found 600 mg/day of Testofen for 6 weeks significantly increased sexual arousal, energy, and orgasm domains. Systematic reviews classify it as having moderate evidence for testosterone support in men.
Fenugreek exhibits hepatoprotective effects supported by animal model studies and emerging clinical data; it reduces hepatic oxidative stress, modulates bile composition, and may protect against liver injury. The NIH LiverTox database confirms no clinically apparent liver toxicity and documented preclinical hepatoprotective activity.
Multiple RCTs demonstrate that standardized fenugreek seed extract significantly alleviates a broad spectrum of menopausal symptoms including hot flashes, night sweats, vaginal dryness, depressive mood, sleep disturbances, and leg/joint pain. Effects are linked to phytoestrogenic compounds raising circulating estradiol.
Fenugreek (Trigonella foenum-graecum) is listed among herbs reported effective for dysmenorrhea in a PMC systematic review. A clinical trial found fenugreek seed powder reduced the severity of primary dysmenorrhea. It contains phytoestrogens and anti-inflammatory compounds with relevance to uterine cramping.
Multiple randomized controlled trials and a 2022 dose-response meta-analysis of 29 RCTs demonstrate that fenugreek supplementation significantly improves the core components of metabolic syndrome (MetS), including fasting plasma glucose, triglycerides, HDL-cholesterol, waist circumference, and systolic blood pressure. Effects on BMI and diastolic blood pressure were not significant. The bioactive compounds diosgenin, 4-hydroxyisoleucine (4-OHIle), and soluble galactomannan fiber are the primary mediators of these metabolic effects. Evidence quality is moderate, with notable heterogeneity across trials warranting cautious interpretation.
Fenugreek has substantial clinical evidence supporting its role in metabolic health, particularly glycemic and lipid regulation. Multiple RCTs and meta-analyses demonstrate significant reductions in fasting blood glucose, HbA1c, triglycerides, and improved insulin sensitivity in individuals with type 2 diabetes or metabolic syndrome. Its primary bioactive constituents—the soluble fiber galactomannan and the amino acid 4-hydroxyisoleucine—are the most studied mechanistic drivers. Evidence is strongest in diabetic populations; effects in healthy individuals are less consistent.
Fenugreek extract has been shown to enhance post-exercise muscle glycogen resynthesis in one RCT, and fenugreek glycosides with anabolic/androgenic activity support muscle protein synthesis and recovery. Evidence on glycogen resynthesis is mixed across two small trials. Its testosterone-modulating effects may further support muscle tissue repair.
Fenugreek (Trigonella foenum-graecum) has been studied in multiple RCTs and included in systematic herbal medicine reviews for PCOS, showing effects on menstrual regularity, androgen reduction, and metabolic parameters. Traditional use in Ayurveda for female hormonal disorders spans centuries.
Fenugreek's phytoestrogenic action is applicable to perimenopause, the transitional period of declining estrogen preceding full menopause. RCT evidence using standardized extracts in women experiencing menopausal symptoms supports benefit for vasomotor, urogenital, and mood-related symptoms that begin during perimenopause.
Fenugreek (Trigonella foenum-graecum) has been used in traditional Ayurvedic and Middle Eastern medicine for physical strength and stamina. Multiple RCTs show fenugreek seed extracts improve muscular endurance, strength, and exercise performance through mechanisms involving testosterone optimization and anabolic signaling. It is among the herbs with strongest evidence for testosterone support in athletes per systematic reviews.
Fenugreek has demonstrated clinical benefit for primary dysmenorrhea (painful menstruation)—a core PMS symptom—in a double-blind RCT showing significant pain reduction and improvement in associated systemic symptoms. Its anti-inflammatory and antispasmodic properties, along with phytoestrogenic action, are the proposed mechanisms.
Fenugreek is one of the most studied herbal galactagogues, with long use in Ayurvedic and Middle Eastern postpartum traditions. A 2018 Thai RCT found fenugreek (with ginger and turmeric) increased breast milk volume by 49% at 2 weeks and 103% at 4 weeks. NIH LactMed and a Cochrane review of galactagogues both document clinical evidence for fenugreek in postpartum lactation support.
Fenugreek seed extract is among the most-studied herbal testosterone boosters, with multiple RCTs and a meta-analysis showing significant increases in total and free testosterone in healthy adult men. The active compounds are believed to be steroidal saponins (fenuside/protodioscin) that inhibit aromatase and 5-alpha-reductase. A 2018 meta-analysis found significant testosterone increases across four studies.
Fenugreek seeds have documented lipid-lowering effects including significant triglyceride reduction in multiple clinical trials. Meta-analyses confirm TG-lowering alongside cholesterol and glucose benefits, particularly in diabetic or prediabetic individuals. Used traditionally in Ayurvedic medicine for metabolic conditions.
Fenugreek seed mucilage has demonstrated gastroprotective effects in animal models, reducing ulcer index in ethanol- and indomethacin-induced gastric ulcers. It is among ten herbs reviewed by Bentham Science for peptic ulcer management. Traditional Ayurvedic and Middle Eastern medicine used fenugreek extensively for gastric complaints.
A fenugreek polysaccharide gel has been shown in animal studies to accelerate cutaneous wound healing, and fenugreek seed extract, oil, and powder have demonstrated acceleration of mucosal wound healing in mice. Human evidence is limited to indirect support from documented mucosal protective effects in the gastrointestinal tract.
Fenugreek (Trigonella foenum-graecum) is a traditional Ayurvedic and Middle Eastern expectorant valued for loosening phlegm and soothing inflamed airways. Its high mucilage content creates a soothing coating effect and stimulates mucus secretion to thin viscous respiratory secretions. Naturopathic pharmacopeias classify it as a soothing expectorant for productive coughs.
Fenugreek (Trigonella foenum-graecum) has traditional use in Ayurvedic and Middle Eastern medicine as a restorative herb for recovery from illness, supporting appetite restoration, energy, and immune function. It contains 4-hydroxyisoleucine, saponins, and diosgenin with anti-inflammatory and immunomodulatory properties. Traditional convalescent use for post-fever weakness is well-documented.
Volver